Correlation Between Edgewise Therapeutics and Galera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Galera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Galera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Galera Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Galera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Galera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Galera Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Galera Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Edgewise and Galera is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Galera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galera Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Galera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galera Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Galera Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Galera Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.39 times more return on investment than Galera Therapeutics. However, Edgewise Therapeutics is 1.39 times more volatile than Galera Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Galera Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 974.00 in Edgewise Therapeutics on August 31, 2024 and sell it today you would earn a total of 2,246 from holding Edgewise Therapeutics or generate 230.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 13.45% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Galera Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Galera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Edgewise Therapeutics and Galera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Galera Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Galera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Galera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galera Therapeutics will offset losses from the drop in Galera Therapeutics' long position.| Edgewise Therapeutics vs. Cue Biopharma | Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx |
| Galera Therapeutics vs. Mereo BioPharma Group | Galera Therapeutics vs. Terns Pharmaceuticals | Galera Therapeutics vs. PDS Biotechnology Corp | Galera Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |